---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-24-000142"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:40:59.782277+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# BioRestorative receives Nasdaq notice for late 10-Q filing; no immediate delisting

## Summary
- Nasdaq notified BioRestorative on May 22, 2024 of non-compliance with Listing Rule 5250(c)(1) due to delinquent Form 10-Q for Q1 2024.
- Notice has no immediate effect on trading; company has 60 days to submit a plan to regain compliance.
- Nasdaq may grant up to 180 calendar days from the 10-Q due date (Nov 11, 2024) for compliance.
- Delay stems from ongoing restatement analysis previously disclosed in the May 24, 2024 Form 8-K.

## SEC filing metadata
- accession: 0001021771-24-000142
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000142/0001021771-24-000142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000142/brt8k522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-24-000142
- JSON: https://secwatch.observer/filing/0001021771-24-000142.json
- Plain text: https://secwatch.observer/filing/0001021771-24-000142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.